HLA-DR antibody (FITC)
Quick Overview for HLA-DR antibody (FITC) (ABIN2704367)
Target
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Purpose
- Anti-HLA-DR FITC Antibody
-
Characteristics
- The L243 reacts with human HLA-DR antigen which is expressed on B lymphocytes, monocytes, macrophages, activated T lymphocytes, activated natural killer (NK) lymphocytes, and human progenitor cells. HLA-DR is also present on thymic epithelium, B lymphocyte dependent areas of spleen and lymph node, and B cell lymphomas.
-
Purification
- Purified
-
Purity
- >95 %
-
Immunogen
- Human B lymphocytes
-
Isotype
- IgG2a, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 100 μg/mL
-
Buffer
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- HLA-DR
-
Alternative Name
- HLA-DR
-
Gene ID
- 3122, 3123
-
NCBI Accession
- NM_019111
-
UniProt
- P01903
-
Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-